目的：探讨肝恶性肿瘤经导管动脉化疗栓塞术(TACE)后出现缺血性并发症的频次、治疗方法和预后。
Purpose: To evaluate the frequency, methods of treatment, and the outcome of ischemic complications after transcatheter arterial chemoembolization (TACE) in hepatic malignant tumors.
探讨肝癌肝动脉栓塞化疗后肿瘤的病理及某些分子生物学的变化。
Objective: To observe the pathological and molecular changes of the primary liver carcinoma after chemoembolization.
结论积极行手术切除肿瘤是胰体尾癌肝转移患者获得长期生存的惟一途径，术中肝动脉栓塞化疗是治疗肝转移灶的重要方法。
Conclusion Radical resection is the unique method for long survival and hepatic arterial embolization chemotherapy in operation is an important way for hepatic metastasis.
随著栓塞次数的增加，会形成一些肝外的侧枝循环供应肿瘤细胞，内乳动脉是其中的一条。
As the number of tace procedures increased, several extrahepatic collateral pathways to hepatic tumors are being developed including the right internal mammary artery.
随著栓塞次数的增加，会形成一些肝外的侧枝循环供应肿瘤细胞，内乳动脉是其中的一条。
As the number of tace procedures increased, several extrahepatic collateral pathways to hepatic tumors are being developed including the right internal mammary artery.
应用推荐